The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
The 24-year-old's music has notched up more than three billion plays and more than 59 million listeners since the service started in 2008.
Blustery, wet and wintry across Scotland today - the sleet and hill snow turning back to rain.
A van driver was caught on camera swerving and weaving across three lanes of a motorway during a high speed police chase.